Arcticzymes Technologies ASA
F:B4V
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arcticzymes Technologies ASA
F:B4V
|
NO |
Intrinsic Value
The intrinsic value of 
Arcticzymes Technologies ASA (B4V) under the Base Case is 1.936 EUR per share.
Compared with the current market price of 1.735 EUR, the stock appears
Undervalued by 10% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Arcticzymes Technologies ASA Does
ArcticZymes Technologies makes specialized enzymes used in life science work, especially in molecular research, diagnostics, and the production of biological medicines. Its products help customers copy, cut, or remove DNA and RNA in lab workflows, which is important for tests, sample preparation, and certain manufacturing steps. The company sells these enzyme products rather than finished consumer goods, so it sits upstream in the biotech supply chain.
- Headquarters
- Norway NO
- Employees
- 53
- IPO date
- Nov 4, 2005
Revenue & Expenses Breakdown
Arcticzymes Technologies ASA
Earnings Waterfall
Arcticzymes Technologies ASA
The intrinsic value for Arcticzymes Technologies ASA (B4V) under the Base Case is 1.936 EUR.
Compared with the current market price of 1.735 EUR, the stock appears Undervalued by 10% .